267 related articles for article (PubMed ID: 34446856)
1. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases.
Jang H; Jo DH; Cho CS; Shin JH; Seo JH; Yu G; Gopalappa R; Kim D; Cho SR; Kim JH; Kim HH
Nat Biomed Eng; 2022 Feb; 6(2):181-194. PubMed ID: 34446856
[TBL] [Abstract][Full Text] [Related]
2. Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration.
She K; Liu Y; Zhao Q; Jin X; Yang Y; Su J; Li R; Song L; Xiao J; Yao S; Lu F; Wei Y; Yang Y
Signal Transduct Target Ther; 2023 Feb; 8(1):57. PubMed ID: 36740702
[TBL] [Abstract][Full Text] [Related]
3. Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice.
Liu P; Liang SQ; Zheng C; Mintzer E; Zhao YG; Ponnienselvan K; Mir A; Sontheimer EJ; Gao G; Flotte TR; Wolfe SA; Xue W
Nat Commun; 2021 Apr; 12(1):2121. PubMed ID: 33837189
[TBL] [Abstract][Full Text] [Related]
4. In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA.
Villiger L; Rothgangl T; Witzigmann D; Oka R; Lin PJC; Qi W; Janjuha S; Berk C; Ringnalda F; Beattie MB; Stoffel M; Thöny B; Hall J; Rehrauer H; van Boxtel R; Tam YK; Schwank G
Nat Biomed Eng; 2021 Feb; 5(2):179-189. PubMed ID: 33495639
[TBL] [Abstract][Full Text] [Related]
5. In vivo prime editing of a metabolic liver disease in mice.
Böck D; Rothgangl T; Villiger L; Schmidheini L; Matsushita M; Mathis N; Ioannidi E; Rimann N; Grisch-Chan HM; Kreutzer S; Kontarakis Z; Kopf M; Thöny B; Schwank G
Sci Transl Med; 2022 Mar; 14(636):eabl9238. PubMed ID: 35294257
[TBL] [Abstract][Full Text] [Related]
6. Adenine base editing and prime editing of chemically derived hepatic progenitors rescue genetic liver disease.
Kim Y; Hong SA; Yu J; Eom J; Jang K; Yoon S; Hong DH; Seo D; Lee SN; Woo JS; Jeong J; Bae S; Choi D
Cell Stem Cell; 2021 Sep; 28(9):1614-1624.e5. PubMed ID: 33951479
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of prime editing outcomes in human embryonic stem cells.
Habib O; Habib G; Hwang GH; Bae S
Nucleic Acids Res; 2022 Jan; 50(2):1187-1197. PubMed ID: 35018468
[TBL] [Abstract][Full Text] [Related]
8. Efficient prime editing in mouse brain, liver and heart with dual AAVs.
Davis JR; Banskota S; Levy JM; Newby GA; Wang X; Anzalone AV; Nelson AT; Chen PJ; Hennes AD; An M; Roh H; Randolph PB; Musunuru K; Liu DR
Nat Biotechnol; 2024 Feb; 42(2):253-264. PubMed ID: 37142705
[TBL] [Abstract][Full Text] [Related]
9. Search-and-replace genome editing without double-strand breaks or donor DNA.
Anzalone AV; Randolph PB; Davis JR; Sousa AA; Koblan LW; Levy JM; Chen PJ; Wilson C; Newby GA; Raguram A; Liu DR
Nature; 2019 Dec; 576(7785):149-157. PubMed ID: 31634902
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Chadwick AC; Wang X; Musunuru K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag.
Liang SQ; Liu P; Ponnienselvan K; Suresh S; Chen Z; Kramme C; Chatterjee P; Zhu LJ; Sontheimer EJ; Xue W; Wolfe SA
Nat Methods; 2023 Jun; 20(6):898-907. PubMed ID: 37156841
[TBL] [Abstract][Full Text] [Related]
12. Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing.
Jo DH; Jang HK; Cho CS; Han JH; Ryu G; Jung Y; Bae S; Kim JH
Mol Ther Nucleic Acids; 2023 Mar; 31():16-27. PubMed ID: 36589710
[TBL] [Abstract][Full Text] [Related]
13. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
[TBL] [Abstract][Full Text] [Related]
14. Precise in vivo functional analysis of DNA variants with base editing using ACEofBASEs target prediction.
Cornean A; Gierten J; Welz B; Mateo JL; Thumberger T; Wittbrodt J
Elife; 2022 Apr; 11():. PubMed ID: 35373735
[TBL] [Abstract][Full Text] [Related]
15. Improvement of base editors and prime editors advances precision genome engineering in plants.
Hua K; Han P; Zhu JK
Plant Physiol; 2022 Mar; 188(4):1795-1810. PubMed ID: 34962995
[TBL] [Abstract][Full Text] [Related]
16. Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis.
Zhou C; Sun Y; Yan R; Liu Y; Zuo E; Gu C; Han L; Wei Y; Hu X; Zeng R; Li Y; Zhou H; Guo F; Yang H
Nature; 2019 Jul; 571(7764):275-278. PubMed ID: 31181567
[TBL] [Abstract][Full Text] [Related]
17. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
[TBL] [Abstract][Full Text] [Related]
18. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.
Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615
[TBL] [Abstract][Full Text] [Related]
19. Prime genome editing in rice and wheat.
Lin Q; Zong Y; Xue C; Wang S; Jin S; Zhu Z; Wang Y; Anzalone AV; Raguram A; Doman JL; Liu DR; Gao C
Nat Biotechnol; 2020 May; 38(5):582-585. PubMed ID: 32393904
[TBL] [Abstract][Full Text] [Related]
20. Introduction of mutations in plants with prime editing.
Hao L; Pu X; Song J
Methods; 2021 Oct; 194():83-93. PubMed ID: 33774158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
